1. A PHASE I/II TRIAL OF IBRUTINIB, INTRATUMORAL CPG AND LOCAL RADIATION IN PATIENTS WITH LOW‐GRADE B‐CELL LYMPHOMA: INTERIM CLINICAL AND CORRELATIVE RESULTS. (12th June 2019) Authors: Shree, T.; Khodadoust, M.S.; Czerwinski, D.; Frank, M.J.; Hong, W.X.; Greenstein, R.; Long, S.; Martin, B.; Levy, R. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IMPAIRED IMMUNE HEALTH IN SURVIVORS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): A LARGE POPULATION‐BASED STUDY. (12th June 2019) Authors: Shree, T.; Li, Q.; Brunson, A.M.; Glaser, S.; Maecker, H.T.; Haile, R.; Levy, R.; Keegan, T.H. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗